Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from Mindbio Therapeutics Corp. ( (TSE:MBIO) ).
MindBio Therapeutics Corp. has engaged Senergy Communications Capital Inc. to enhance its marketing and investor awareness efforts. This collaboration involves Senergy executing comprehensive campaigns focused on corporate branding and digital marketing, with an initial three-month term and a fee of CAD$150,000. This strategic move aims to bolster MindBio’s market presence and stakeholder engagement.
More about Mindbio Therapeutics Corp.
MindBio Therapeutics Corp. is a clinical-stage biotechnology company based in Vancouver, British Columbia, specializing in developing novel treatments for mental health disorders and health prediction technologies using AI and machine learning. The company is known for its expertise in developing speech analytics as a prediction tool for drug and alcohol intoxication.
Average Trading Volume: 2,564
Technical Sentiment Signal: Sell
Current Market Cap: C$6.75M
Learn more about MBIO stock on TipRanks’ Stock Analysis page.